- Home
- UG vs VTVT Comparison
UG vs VTVT Comparison
Compare UG & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UG
- VTVT
- Stock Information
- Founded
- UG 1942
- VTVT 2015
- Country
- UG United States
- VTVT United States
- Employees
- UG N/A
- VTVT N/A
- Industry
- UG Package Goods/Cosmetics
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- UG Consumer Discretionary
- VTVT Health Care
- Exchange
- UG Nasdaq
- VTVT Nasdaq
- Market Cap
- UG 36.8M
- VTVT N/A
- IPO Year
- UG N/A
- VTVT 2015
- Fundamental
- Price
- UG $8.03
- VTVT $20.08
- Analyst Decision
- UG
- VTVT Strong Buy
- Analyst Count
- UG 0
- VTVT 2
- Target Price
- UG N/A
- VTVT $35.50
- AVG Volume (30 Days)
- UG 12.8K
- VTVT 8.5K
- Earning Date
- UG 05-08-2025
- VTVT 05-20-2025
- Dividend Yield
- UG 8.72%
- VTVT N/A
- EPS Growth
- UG 4.82
- VTVT N/A
- EPS
- UG 0.63
- VTVT N/A
- Revenue
- UG $11,408,154.00
- VTVT $1,017,000.00
- Revenue This Year
- UG N/A
- VTVT N/A
- Revenue Next Year
- UG N/A
- VTVT N/A
- P/E Ratio
- UG $11.28
- VTVT N/A
- Revenue Growth
- UG N/A
- VTVT N/A
- 52 Week Low
- UG $7.73
- VTVT $12.12
- 52 Week High
- UG $16.25
- VTVT $29.01
- Technical
- Relative Strength Index (RSI)
- UG 41.60
- VTVT 50.66
- Support Level
- UG $7.85
- VTVT $19.49
- Resistance Level
- UG $8.44
- VTVT $22.37
- Average True Range (ATR)
- UG 0.39
- VTVT 1.28
- MACD
- UG 0.03
- VTVT -0.14
- Stochastic Oscillator
- UG 22.14
- VTVT 27.61
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.